Kim Deok-bae, Chief Director of Balgeun Eye Clinic 21 Hospital, Participates in Online Discussion
[Asia Economy Honam Reporting Headquarters Reporter Park Jin-hyung] The '2022 POWER SYMPOSIUM' hosted by Bayer Korea AILIA Team was held online and offline for one night and two days from the 22nd to the 23rd at the Conrad Seoul Hotel.
The '2022 POWER SYMPOSIUM' is a global academic research forum that invites outstanding ophthalmologists from home and abroad to explore and share new research trends, clinical experiences, and surgical methods in the field of ophthalmology.
Kim Deok-bae, CEO of Bright Eye 21 Hospital, participated as an online panelist in the final session on the 23rd, titled 'Early intensive treatment in DME (Diabetic Macular Edema)'.
The online discussion included five retinal specialists from across the country, including CEO Kim Deok-bae, and featured in-depth discussions on how effective early intensive treatment using Aflibercept, the latest treatment for diabetic retinopathy, is for diabetic macular edema.
CEO Kim Deok-bae presented that based on research on patients with diabetic macular edema, early intensive treatment is important; however, since it requires significant cost and time, the best treatment method considers the patient's economic situation, age, and regional characteristics together.
Additionally, the event provided a meaningful opportunity not only for academic exchange but also for practical assistance in treatment by sharing accumulated surgical know-how and insights with medical professionals.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
CEO Kim said, “Although I attended the symposium online due to COVID-19, it was a valuable time to share diverse opinions,” and added, “Bright Eye 21 Hospital will continue to devote itself to research activities to deliver safe and successful treatment and surgical outcomes to patients.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
